Clopidogrel works by blocking ADP receptors, which prevents platelet activation and the formation of blood clots.

Aspirin and other NSAIDs inhibit the COX-1 enzyme, leading to a decrease in prostaglandins and thromboxane, which helps to prevent blood clots.

Antiplatelet medications like abciximab and eptifibatide work by blocking glycoprotein IIb/IIIa receptors on platelets, which prevents platelet adhesion and activation.

Increasing thrombomodulin expression and prostacyclin levels would have the opposite effect and increase blood coagulability and platelet production.

Clopidogrel: An Antiplatelet Agent for Cardiovascular Disease

Clopidogrel is a medication used to manage cardiovascular disease by preventing platelets from sticking together and forming clots. It is commonly used in patients with acute coronary syndrome and is now also recommended as a first-line treatment for patients following an ischaemic stroke or with peripheral arterial disease. Clopidogrel belongs to a class of drugs called thienopyridines, which work in a similar way. Other examples of thienopyridines include prasugrel, ticagrelor, and ticlopidine.

Clopidogrel works by blocking the P2Y12 adenosine diphosphate (ADP) receptor, which prevents platelets from becoming activated. However, concurrent use of proton pump inhibitors (PPIs) may make clopidogrel less effective. The Medicines and Healthcare products Regulatory Agency (MHRA) issued a warning in July 2009 about this interaction, and although evidence is inconsistent, omeprazole and esomeprazole are still cause for concern. Other PPIs, such as lansoprazole, are generally considered safe to use with clopidogrel. It is important to consult with a healthcare provider before taking any new medications or supplements.

The heart receives blood supply from the coronary arteries, which originate from the left side of the heart at the root of the aorta as it exits the left ventricle.

The left coronary artery (LCA) provides blood to the left atrium and ventricle, as well as the interventricular septum. The circumflex artery, a branch of the LCA, supplies the lateral aspect of the left heart by following the coronary sulcus to the left. The left anterior descending artery (LAD), another major branch of the LCA, supplies the anteroseptal part of the heart by following the anterior interventricular sulcus around the pulmonary trunk.

The right coronary artery (RCA) follows the coronary sulcus and supplies blood to the right atrium, portions of both ventricles, and the inferior aspect of the heart. The marginal arteries, which arise from the RCA, provide blood to the superficial portions of the right ventricle. The posterior descending artery, which branches off the RCA on the posterior surface of the heart, runs along the posterior portion of the interventricular sulcus toward the apex of the heart and supplies the interventricular septum and portions of both ventricles.

The following table displays the relationship between ECG changes and the affected coronary artery territories. Anteroseptal changes in V1-V4 indicate involvement of the left anterior descending artery, while inferior changes in II, III, and aVF suggest the right coronary artery is affected. Anterolateral changes in V4-6, I, and aVL may indicate involvement of either the left anterior descending or left circumflex artery, while lateral changes in I, aVL, and possibly V5-6 suggest the left circumflex artery is affected. Posterior changes in V1-3 may indicate a posterior infarction, which is typically caused by the left circumflex artery but can also be caused by the right coronary artery. Reciprocal changes of STEMI are often seen as horizontal ST depression, tall R waves, upright T waves, and a dominant R wave in V2. Posterior infarction is confirmed by ST elevation and Q waves in posterior leads (V7-9), usually caused by the left circumflex artery but also possibly the right coronary artery. It is important to note that a new LBBB may indicate acute coronary syndrome.

Diagram showing the correlation between ECG changes and coronary territories in acute coronary syndrome.

The man is experiencing critical ischemia, which is a severe form of peripheral arterial disease. He has progressed from experiencing claudication (similar to angina of the leg) to experiencing pain even at rest. While lifestyle changes and medication such as aspirin and statins are important, surgical intervention is necessary in this case. His ABPI is very low, indicating arterial disease, and percutaneous transluminal angioplasty is the preferred surgical option due to its minimally invasive nature. Amputation is not recommended at this stage as the tissue is still viable.

Symptoms of peripheral arterial disease include no symptoms, claudication, leg pain at rest, ulceration, and gangrene. Signs include absent leg and foot pulses, cold white legs, atrophic skin, arterial ulcers, and long capillary filling time (over 15 seconds in severe ischemia). The first line investigation is ABPI, and imaging options include colour duplex ultrasound and MR/CT angiography if intervention is being considered.

Management involves modifying risk factors such as smoking cessation, treating hypertension and high cholesterol, and prescribing clopidogrel. Supervised exercise programs can also help increase blood flow. Surgical options include percutaneous transluminal angioplasty and surgical reconstruction using the saphenous vein as a bypass graft. Amputation may be necessary in severe cases.

Understanding Ankle Brachial Pressure Index (ABPI)

Ankle Brachial Pressure Index (ABPI) is a non-invasive test used to assess the blood flow in the legs. It is a simple and quick test that compares the blood pressure in the ankle with the blood pressure in the arm. The result is expressed as a ratio, with the normal value being 1.0.

ABPI is particularly useful in the assessment of peripheral arterial disease (PAD), which is a condition that affects the blood vessels outside the heart and brain. PAD can cause intermittent claudication, which is a cramping pain in the legs that occurs during exercise and is relieved by rest.

The interpretation of ABPI results is as follows: a ratio between 0.6 and 0.9 is indicative of claudication, while a ratio between 0.3 and 0.6 suggests rest pain. A ratio below 0.3 indicates impending limb loss and requires urgent intervention.

BNP has several actions, including vasodilation which can decrease cardiac afterload, diuretic and natriuretic effects, and suppression of both sympathetic tone and the renin-angiotensin-aldosterone system. In the case of heart failure, BNP is primarily secreted by the ventricular myocardium to compensate for symptoms by promoting diuresis, natriuresis, vasodilation, and suppression of sympathetic tone and renin-angiotensin-aldosterone activity. Vasodilation of the peripheral vascular system leads to a decrease in afterload, reducing the force that the left ventricle has to contract against and lowering the risk of left ventricular failure progression. BNP also suppresses sympathetic tone and the RAAS, which would exacerbate heart failure symptoms, and contributes to natriuresis, aiding diuresis and improving dyspnea.

B-type natriuretic peptide (BNP) is a hormone that is primarily produced by the left ventricular myocardium in response to strain. Although heart failure is the most common cause of elevated BNP levels, any condition that causes left ventricular dysfunction, such as myocardial ischemia or valvular disease, may also raise levels. In patients with chronic kidney disease, reduced excretion may also lead to elevated BNP levels. Conversely, treatment with ACE inhibitors, angiotensin-2 receptor blockers, and diuretics can lower BNP levels.

BNP has several effects, including vasodilation, diuresis, natriuresis, and suppression of both sympathetic tone and the renin-angiotensin-aldosterone system. Clinically, BNP is useful in diagnosing patients with acute dyspnea. A low concentration of BNP (<100 pg/mL) makes a diagnosis of heart failure unlikely, but elevated levels should prompt further investigation to confirm the diagnosis. Currently, NICE recommends BNP as a helpful test to rule out a diagnosis of heart failure. In patients with chronic heart failure, initial evidence suggests that BNP is an extremely useful marker of prognosis and can guide treatment. However, BNP is not currently recommended for population screening for cardiac dysfunction.

There is no indication of trauma in patients with advanced renal failure prior to dialysis initiation.

ECG results do not indicate a recent heart attack.

The patient’s age decreases the likelihood of malignancy.

Acute Pericarditis: Causes, Features, Investigations, and Management

Acute pericarditis is a possible diagnosis for patients presenting with chest pain. The condition is characterized by chest pain, which may be pleuritic and relieved by sitting forwards. Other symptoms include non-productive cough, dyspnoea, and flu-like symptoms. Tachypnoea and tachycardia may also be present, along with a pericardial rub.

The causes of acute pericarditis include viral infections, tuberculosis, uraemia, trauma, post-myocardial infarction, Dressler’s syndrome, connective tissue disease, hypothyroidism, and malignancy.

Investigations for acute pericarditis include ECG changes, which are often global/widespread, as opposed to the ‘territories’ seen in ischaemic events. The ECG may show ‘saddle-shaped’ ST elevation and PR depression, which is the most specific ECG marker for pericarditis. All patients with suspected acute pericarditis should have transthoracic echocardiography.

Management of acute pericarditis involves treating the underlying cause. A combination of NSAIDs and colchicine is now generally used as first-line treatment for patients with acute idiopathic or viral pericarditis.

In summary, acute pericarditis is a possible diagnosis for patients presenting with chest pain. The condition is characterized by chest pain, which may be pleuritic and relieved by sitting forwards, along with other symptoms. The causes of acute pericarditis are varied, and investigations include ECG changes and transthoracic echocardiography. Management involves treating the underlying cause and using a combination of NSAIDs and colchicine as first-line treatment.

Understanding the Cardiac Action Potential and Conduction Velocity

The cardiac action potential is a series of electrical events that occur in the heart during each heartbeat. It is responsible for the contraction of the heart muscle and the pumping of blood throughout the body. The action potential is divided into five phases, each with a specific mechanism. The first phase is rapid depolarization, which is caused by the influx of sodium ions. The second phase is early repolarization, which is caused by the efflux of potassium ions. The third phase is the plateau phase, which is caused by the slow influx of calcium ions. The fourth phase is final repolarization, which is caused by the efflux of potassium ions. The final phase is the restoration of ionic concentrations, which is achieved by the Na+/K+ ATPase pump.

Conduction velocity is the speed at which the electrical signal travels through the heart. The speed varies depending on the location of the signal. Atrial conduction spreads along ordinary atrial myocardial fibers at a speed of 1 m/sec. AV node conduction is much slower, at 0.05 m/sec. Ventricular conduction is the fastest in the heart, achieved by the large diameter of the Purkinje fibers, which can achieve velocities of 2-4 m/sec. This allows for a rapid and coordinated contraction of the ventricles, which is essential for the proper functioning of the heart. Understanding the cardiac action potential and conduction velocity is crucial for diagnosing and treating heart conditions.

The left internal thoracic artery originates from the left subclavian artery near its source and runs down the chest wall beneath the ribs to supply blood to the front of the chest and breasts. During coronary artery bypass grafting (CABG), the proximal portion of the ITA is preserved while the distal end is grafted beyond the atherosclerotic segment of the affected coronary vessel to restore blood flow to the heart.

The left axillary artery is a continuation of the left subclavian artery and is referred to as the axillary artery beyond the lateral border of the first rib. It becomes the brachial artery after passing the lower border of the teres major muscle.

The left common carotid artery emerges from the aortic arch and divides into the internal and external carotid arteries at the fourth cervical vertebrae.

The aortic arch is a continuation of the ascending aorta and branches off into the right brachiocephalic trunk, the left common carotid artery, and the left subclavian artery before continuing as the descending aorta.

The thyrocervical trunk, which arises from the subclavian artery, is a brief vessel that gives rise to four branches: the inferior thyroid artery, suprascapular artery, ascending cervical artery, and transverse cervical artery.

Coronary Artery Bypass Grafting (CABG)

Coronary artery bypass grafting (CABG) is a surgical procedure commonly used to treat coronary artery disease. The procedure involves using multiple grafts, with the internal mammary artery being increasingly used instead of the saphenous vein due to its lower likelihood of narrowing. The surgery requires the use of a heart-lung bypass machine and systemic anticoagulation. Suitability for the procedure is determined by cardiac catheterisation or angiography. The surgery is carried out under general anaesthesia, and patients typically stay in the hospital for 7-10 days, with a return to work within 3 months.

Complications of CABG include atrial fibrillation (30-40% of cases, usually self-limiting) and stroke (2%). However, the prognosis for the procedure is generally positive, with 90% of operations being successful. Further revascularisation may be needed in 5-10% of cases after 5 years, but the mortality rate is low, at 1-2% at 30 days.

Rheumatic heart fever is characterized by the presence of Aschoff bodies, which are granulomatous nodules. The mitral valve is commonly affected in this condition, and an elevated ASO titre indicates exposure to group A streptococcus bacteria. Rheumatic heart disease is also associated with the presence of Anitschkow cells, which are enlarged macrophages with an ovoid, wavy, rod-like nucleus. Other types of bodies seen in different conditions include Councilman bodies in hepatitis C and yellow fever, Mallory bodies in alcoholism affecting hepatocytes, and Call-Exner bodies in granulosa cell tumours.

Rheumatic fever is a condition that occurs as a result of an immune response to a recent Streptococcus pyogenes infection, typically occurring 2-4 weeks after the initial infection. The pathogenesis of rheumatic fever involves the activation of the innate immune system, leading to antigen presentation to T cells. B and T cells then produce IgG and IgM antibodies, and CD4+ T cells are activated. This immune response is thought to be cross-reactive, mediated by molecular mimicry, where antibodies against M protein cross-react with myosin and the smooth muscle of arteries. This response leads to the clinical features of rheumatic fever, including Aschoff bodies, which are granulomatous nodules found in rheumatic heart fever.

To diagnose rheumatic fever, evidence of recent streptococcal infection must be present, along with 2 major criteria or 1 major criterion and 2 minor criteria. Major criteria include erythema marginatum, Sydenham’s chorea, polyarthritis, carditis and valvulitis, and subcutaneous nodules. Minor criteria include raised ESR or CRP, pyrexia, arthralgia, and prolonged PR interval.

Management of rheumatic fever involves antibiotics, typically oral penicillin V, as well as anti-inflammatories such as NSAIDs as first-line treatment. Any complications that develop, such as heart failure, should also be treated. It is important to diagnose and treat rheumatic fever promptly to prevent long-term complications such as rheumatic heart disease.

The presence of S4, which sounds like a ‘gallop rhythm’, can be heard after S2 and in conjunction with a third heart sound. However, if the ventricles are contracting against a stiffened aorta, it would not produce a significant heart sound during this phase of the cardiac cycle. Any sound that may be heard in this scenario would occur between the first and second heart sounds during systole, and it would also cause a raised pulse pressure and be visible on chest X-ray as calcification. Delayed closure of the aortic valve could cause a split second heart sound, but it would appear around the time of S2, not before S1. On the other hand, retrograde flow of blood from the right ventricle into the right atrium, known as tricuspid regurgitation, would cause a systolic murmur instead of an additional isolated heart sound. This condition is often caused by infective endocarditis in intravenous drug users or a history of rheumatic fever.

Heart sounds are the sounds produced by the heart during its normal functioning. The first heart sound (S1) is caused by the closure of the mitral and tricuspid valves, while the second heart sound (S2) is due to the closure of the aortic and pulmonary valves. The intensity of these sounds can vary depending on the condition of the valves and the heart. The third heart sound (S3) is caused by the diastolic filling of the ventricle and is considered normal in young individuals. However, it may indicate left ventricular failure, constrictive pericarditis, or mitral regurgitation in older individuals. The fourth heart sound (S4) may be heard in conditions such as aortic stenosis, HOCM, and hypertension, and is caused by atrial contraction against a stiff ventricle. The different valves can be best heard at specific sites on the chest wall, such as the left second intercostal space for the pulmonary valve and the right second intercostal space for the aortic valve.

The heart is supplied with blood by the coronary arteries, which branch off from the aorta. The right coronary artery supplies blood to the right side of the heart, while the left coronary artery supplies blood to the left side of the heart.

Occlusion, or blockage, of the right coronary artery can cause inferior myocardial infarction (MI), which is indicated on an electrocardiogram (ECG) by changes in leads II, III, and aVF. This type of MI is particularly associated with arrhythmias because the right coronary artery usually supplies the sinoatrial (SA) and atrioventricular (AV) nodes.

The left anterior descending artery (LAD) is one of the two branches of the left coronary artery. It runs along the front of the heart’s interventricular septum to reach the apex of the heart. One or more diagonal branches may arise from the LAD. Occlusion of the LAD can cause anteroseptal MI, which is evident on an ECG with changes in leads V1-V4.

The right marginal artery branches off from the right coronary artery near the bottom of the heart and continues along the heart’s bottom edge towards the apex.

The left circumflex artery is the other branch of the left coronary artery. It runs in the coronary sulcus around the base of the heart and gives rise to the left marginal artery. Occlusion of the left circumflex artery is typically associated with lateral MI.

The left marginal artery arises from the left circumflex artery and runs along the heart’s obtuse margin.

The walls of each cardiac chamber are made up of the epicardium, myocardium, and endocardium. The heart and roots of the great vessels are related anteriorly to the sternum and the left ribs. The coronary sinus receives blood from the cardiac veins, and the aortic sinus gives rise to the right and left coronary arteries. The left ventricle has a thicker wall and more numerous trabeculae carnae than the right ventricle. The heart is innervated by autonomic nerve fibers from the cardiac plexus, and the parasympathetic supply comes from the vagus nerves. The heart has four valves: the mitral, aortic, pulmonary, and tricuspid valves.